ARCHIVES

In Brief: NCI Gets $937 Million For FY 79 As Congress Adjourns; Cancer Act Renewed For Two Years

This article is from The Cancer Letter archive.

Vol. 04 No. 42 | October 20, 1978

Download PDF Visit The Full Archive

Related Articles

High Response Rate of Hairy Cell Leukemia Patients to Immunotoxin Treatment In Phase I

April 27, 2001

First-Line Bendamustine Doubles PFS In Non-Hodgkin and Mantle Cell Lymphoma

February 22, 2013

Budget Resolution Includes Extra Money For NCI

July 2, 1982

FDA Grants Accelerated Approval to Imbruvica

November 29, 2013

In Brief: Christopher Walsh Named Dana-Farber President; Sachs Leaves NCI; Acoustic Neuroma Conference

August 16, 1991

In Brief: Elion, Schein, Johnson Head Societies; Phillips, Salmon Elected; McIntire, Pistenma to Leave NCI

June 3, 1983